Chicago Psychiatry team, What happened??

[anonymous]

But wait Latuda has great clinical data. At least that’s what that 1 delusional drone keeps trying to hang his hat on. Who cares if Sunovion is cheap and under paying reps causing a massive turnover. Maybe all thats needed is more roll playing the clinical data and all will be fixed. Boy they have some dumb ass drones here. Lmao

WOOF!!

 

[anonymous]

WOOF!!

xcept that we had better to and efficacy data, and more dose flexibility. If people understood this and practiced role playing the data, the company would not be in this position. Just know the data people! Geeeez

 

[anonymous]

But wait Latuda has great clinical data. At least that’s what that 1 delusional drone keeps trying to hang his hat on. Who cares if Sunovion is cheap and under paying reps causing a massive turnover. Maybe all thats needed is more roll playing the clinical data and all will be fixed. Boy they have some dumb ass drones here. Lmao

why would any adult want to play with a roll? Sounds really dumb to me. Are you a drone?

 

[anonymous]

why would any adult want to play with a roll? Sounds really dumb to me. Are you a drone?

I love playing with rolls, especially when I puts lots and lots of butter on them! But I heave never liked role playing!

 

[anonymous]

xcept that we had better to and efficacy data, and more dose flexibility. If people understood this and practiced role playing the data, the company would not be in this position. Just know the data people! Geeeez

What a stool head sunovion homer.

 

[anonymous]

I love playing with rolls, especially when I puts lots and lots of butter on them! But I heave never liked role playing!

I get illuminated by my Mgr when I role play Lutuda studies at POAs. It’s special.

 

[anonymous]

What a stool head sunovion homer.

Still here? Beat it, bitch! WOOF!!

 

[anonymous]

Still here? Beat it, bitch! WOOF!!

we had better to and efficacy data, and more dose flexibility. The mass exodus is due to reps not understanding the data.

 

[anonymous]

What we really need in Chicago is Tony back.

I second that, bring Tony back. He was so lovable! He knew the reality of our situation.

 

[anonymous]

we had better to and efficacy data, and more dose flexibility. The mass exodus is due to reps not understanding the data.

What a blow hard dweeb.

 

[anonymous]

What a blow hard dweeb.

Still trolling the board of your former employer?

 

[anonymous]

I second that, bring Tony back. He was so lovable! He knew the reality of our situation.

Just curious what rock have you been hiding under? Massive departures and you think it’s over some useless clinical paper? Did you ever think why the company sent out that lame salary survey? Wake up!

 

[anonymous]

we had better to and efficacy data, and more dose flexibility. The mass exodus is due to reps not understanding the data.

 

[anonymous]

If I want to pursue a career in sales with Sunovion, would it be a wise move to apply for the open positions in the Chicago/Indianapolis area? looks like Latuda has a few more years for patent exclusivity. Any other drug in the pipeline worth investing a sales job on? I have 10+ years in pharma, what should I expect as a base?
Kind answers please.

 

[anonymous]

Can you learn clinical study data? Our data is stout and owns the market. As far as base pay, what do you make now? Depending on that, you could get 4-8% bump if Mgr feels you are good enough.